Patents by Inventor Lars Ostberg

Lars Ostberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
    Publication number: 20080260730
    Abstract: The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon ?.
    Type: Application
    Filed: May 24, 2007
    Publication date: October 23, 2008
    Applicant: PDL BioPharma, Inc.
    Inventors: Rolf Ehrhardt, Daniel J. Levitt, Beth Layug, Don O'Neill, Nancy Wedel, Lars Ostberg
  • Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
    Publication number: 20050019323
    Abstract: The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon ?.
    Type: Application
    Filed: March 19, 2004
    Publication date: January 27, 2005
    Applicant: Protein Design Labs, Inc.
    Inventors: Rolf Ehrhardt, Daniel Levitt, Beth Layug, Don O'Neill, Nancy Wedel, Lars Ostberg
  • Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
    Publication number: 20040052791
    Abstract: The present invention provides a method of treating autoimmune diseases. In particular, it provides a method for the treatment of Crohn's disease or psoriasis comprising administering to a subject in need thereof a therapeutically effective amount of an antibody against interferon &ggr;.
    Type: Application
    Filed: May 16, 2003
    Publication date: March 18, 2004
    Inventors: Rolf Ehrhardt, Dan Levitt, Beth Layug, Donald O'Neill, Nancy Wedel, Lars Ostberg
  • Human antibodies against varicella-zoster virus
    Patent number: 5506132
    Abstract: The invention provides human monoclonal antibodies specific for the glycoprotein II subunit of Varicella-zoster virus. Preferred antibodies exhibit strong complement-independent neutralizing activity, antibody dependent cellular cytotoxicity, and cross-reactivity with multiple strains of Varicella-zoster virus.
    Type: Grant
    Filed: March 24, 1994
    Date of Patent: April 9, 1996
    Assignee: Sandoz Pharmaceuticals Corporation
    Inventors: Philip Lake, Lars Ostberg